Assessment of association between clinical characteristics and prostate specific antigen (PSA) progression in men with prostate cancer receiving a leuprorelin acetate implant: results from the non-interventional German cohort LEAN study

By: Schmitz-Dräger B.2, Mühlich S.3, Ottillinger B.1, Studen M.4
Institutes: 1Ottillinger Life Sciences, Hofolding, Germany, 2Schön Klinik Nürnberg Fürth, Dept. of Urology, Fürth, Germany, 3Practice Nuclear Medicine, Dept. of Urology, Bamberg, Germany, 4Hexal AG, Medical Affairs, Holzkirchen, Germany
  • Event: 9th European Multidisciplinary congress on Urological Cancers
  • Type: Document
  • Date: 16-11-2017
  • Views: 463
  • Nr: P052